Physician
Oncology
Dr. Gerard T. Kennealey, MD
|
|
Give Review
Gerard Kennealey works in the field of Oncology. He went to Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. Gerard T. Kennealey, MD has written publications. He has 22 publications published with PubMed. The lastest publication is: '''Tomudex'' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. ''Tomudex'' International Study Group.'
Publications
- Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group.
- ''Tomudex'' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. ''Tomudex'' International Study Group.
- Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors.
- Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial.
- Cancer chemotherapeutic and biologic agents.
- Prognostic factors in stage D2 prostate cancer treated with a pure nonsteroidal antiandrogen.
- Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group.
- Re: A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia.
- Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma.
- Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy and long-term endocrine effects ...
- Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
- Modification of response to histocompatibility antigens with chemotherapeutic agents.
- Patients' choice of treatment in stage D prostate cancer.
- Use of the nonsteroidal anti-androgen Casodex in advanced prostatic carcinoma.
- Gonadotropin-releasing hormone and its analogues.
- A comparison of Zoladex and DES in the treatment of advanced prostate cancer: results of a randomized, multicenter trial.
- Recent developments in endocrine treatment of prostate cancer.
- Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group.
- Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
- Sjögren's syndrome with pseudolymphoma 13 years after Hodgkin's disease.
- Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.
Schools
Yale University
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Yale-New Haven Hospital -
Yale University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Victor Sandor, MD |
|
|
Dr. Yogishchandra A. Patel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert W. Frelick, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Evan H. Crain, MD
This Doctor is OpenDoctor Recommended.
|